BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22576594)

  • 1. [Congestive heart failure: reverse cardiac remodeling mediated by left ventricular assist devices].
    Wohlschläger J; Milting H; Stypmann J; Hager T; Schmid C; Levkau B; Baba HA
    Pathologe; 2012 May; 33(3):175-82. PubMed ID: 22576594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
    Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
    Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of metallothionein expression is different throughout the human myocardium after prolonged left-ventricular mechanical support.
    Baba HA; Grabellus F; August C; Plenz G; Takeda A; Tjan TD; Schmid C; Deng MC
    J Heart Lung Transplant; 2000 Jul; 19(7):668-74. PubMed ID: 10930816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
    Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Left ventricular assist devices (LVAD): optional treatment alternative to cardiac transplantation?].
    Wohlschlaeger J; Kawaguchi N; Levkau B; Schmid C; Scheld HH; Baba HA
    Verh Dtsch Ges Pathol; 2004; 88():113-21. PubMed ID: 16892541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degree of cardiac fibrosis and hypertrophy at time of implantation predicts myocardial improvement during left ventricular assist device support.
    Bruckner BA; Razeghi P; Stetson S; Thompson L; Lafuente J; Entman M; Loebe M; Noon G; Taegtmeyer H; Frazier OH; Youker K
    J Heart Lung Transplant; 2004 Jan; 23(1):36-42. PubMed ID: 14734125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin-proteasome system: A potential therapeutic target for heart failure.
    Barac YD; Emrich F; Krutzwakd-Josefson E; Schrepfer S; Sampaio LC; Willerson JT; Robbins RC; Ciechanover A; Mohr FW; Aravot D; Taylor DA
    J Heart Lung Transplant; 2017 Jul; 36(7):708-714. PubMed ID: 28341100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
    Klotz S; Naka Y; Oz MC; Burkhoff D
    J Heart Lung Transplant; 2005 Sep; 24(9):1195-201. PubMed ID: 16143233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure.
    Welp H; Rukosujew A; Tjan TD; Hoffmeier A; Kösek V; Scheld HH; Drees G
    Thorac Cardiovasc Surg; 2010 Feb; 58 Suppl 2():S185-8. PubMed ID: 20101537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action.
    Drakos SG; Kfoury AG; Selzman CH; Verma DR; Nanas JN; Li DY; Stehlik J
    Curr Opin Cardiol; 2011 May; 26(3):245-55. PubMed ID: 21451407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support.
    Rodrigue-Way A; Burkhoff D; Geesaman BJ; Golden S; Xu J; Pollman MJ; Donoghue M; Jeyaseelan R; Houser S; Breitbart RE; Marks A; Acton S
    J Heart Lung Transplant; 2005 Jan; 24(1):73-80. PubMed ID: 15653383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and molecular changes of the myocardium after left ventricular mechanical support.
    Baba HA; Wohlschlaeger J
    Curr Cardiol Rev; 2008 Aug; 4(3):157-69. PubMed ID: 19936192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failure.
    Miyagawa S; Toda K; Nakamura T; Yoshikawa Y; Fukushima S; Saito S; Yoshioka D; Saito T; Sawa Y
    Surg Today; 2016 Feb; 46(2):149-54. PubMed ID: 25840890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular unloading is associated with increased 20s proteasome protein expression in the myocardium.
    Wohlschlaeger J; Sixt SU; Stoeppler T; Schmitz KJ; Levkau B; Tsagakis K; Vahlhaus C; Schmid C; Peters J; Schmid KW; Milting H; Baba HA
    J Heart Lung Transplant; 2010 Jan; 29(1):125-32. PubMed ID: 19837610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem Cell and Left Ventricular Assist Device Combination Therapy.
    Poglajen G; Gregoric ID; Radovancevic R; Vrtovec B
    Circ Heart Fail; 2019 Feb; 12(2):e005454. PubMed ID: 30759999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, molecular, and genomic changes in response to a left ventricular assist device.
    Hall JL; Fermin DR; Birks EJ; Barton PJ; Slaughter M; Eckman P; Baba HA; Wohlschlaeger J; Miller LW
    J Am Coll Cardiol; 2011 Feb; 57(6):641-52. PubMed ID: 21292124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist.
    Saito S; Matsumiya G; Sakaguchi T; Miyagawa S; Yamauchi T; Kuratani T; Sawa Y
    J Heart Lung Transplant; 2010 Jun; 29(6):672-9. PubMed ID: 20188595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of cellular hypertrophy after left ventricular assist device support.
    Zafeiridis A; Jeevanandam V; Houser SR; Margulies KB
    Circulation; 1998 Aug; 98(7):656-62. PubMed ID: 9715858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular evidence of reverse cardiac remodeling induced by cardiac resynchronization therapy.
    Orrego CM; Nasir N; Oliveira GH; Flores-Arredondo JH; Cordero-Reyes AM; Loebe M; Youker KA; Torre-Amione G
    Congest Heart Fail; 2011; 17(3):140-6. PubMed ID: 21609388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.